Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Research Site, St. Paul, Minnesota, United States
Research Site, London, United Kingdom
Research Site, St Paul, Minnesota, United States
Research Site, Stockholm, Sweden
Research Site, Leon, Guanajuato, Mexico
Professor Joanna Zakrzewska, London, United Kingdom
Hopital Pitie Salpetriere, Paris, France
Pfizer Investigational Site, Long Beach, California, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, New Haven, Connecticut, United States